0001391437 2026-01-01 2026-06-30 0001391437 grx:CommonStocksMember 2026-01-01 2026-06-30 0001391437 grx:CommonStocksMember 2026-06-30 0001391437 grx:SeriesCCumulativePreferredStockMember 2026-06-30 0001391437 grx:SeriesCCumulativePreferredStockMember 2025-12-31 0001391437 grx:SeriesCCumulativePreferredStockMember 2024-12-31 0001391437 grx:SeriesCCumulativePreferredStockMember 2023-12-31 0001391437 grx:SeriesCCumulativePreferredStockMember 2022-12-31 0001391437 grx:SeriesCCumulativePreferredStockMember 2021-12-31 0001391437 grx:SeriesCCumulativePreferredStockMember 2026-01-01 2026-06-30 0001391437 grx:SeriesCCumulativePreferredStockMember 2025-01-01 2025-12-31 0001391437 grx:SeriesCCumulativePreferredStockMember 2024-01-01 2024-12-31 0001391437 grx:SeriesCCumulativePreferredStockMember 2023-01-01 2023-12-31 0001391437 grx:SeriesCCumulativePreferredStockMember 2022-01-01 2022-12-31 0001391437 grx:SeriesCCumulativePreferredStockMember 2021-01-01 2021-12-31 0001391437 grx:SeriesECumulativePreferredStockMember 2026-06-30 0001391437 grx:SeriesECumulativePreferredStockMember 2025-12-31 0001391437 grx:SeriesECumulativePreferredStockMember 2024-12-31 0001391437 grx:SeriesECumulativePreferredStockMember 2023-12-31 0001391437 grx:SeriesECumulativePreferredStockMember 2022-12-31 0001391437 grx:SeriesECumulativePreferredStockMember 2021-12-31 0001391437 grx:SeriesECumulativePreferredStockMember 2026-01-01 2026-06-30 0001391437 grx:SeriesECumulativePreferredStockMember 2025-01-01 2025-12-31 0001391437 grx:SeriesECumulativePreferredStockMember 2024-01-01 2024-12-31 0001391437 grx:SeriesECumulativePreferredStockMember 2023-01-01 2023-12-31 0001391437 grx:SeriesECumulativePreferredStockMember 2022-01-01 2022-12-31 0001391437 grx:SeriesECumulativePreferredStockMember 2021-01-01 2021-12-31 0001391437 grx:SeriesGCumulativePreferredStockMember 2026-06-30 0001391437 grx:SeriesGCumulativePreferredStockMember 2025-12-31 0001391437 grx:SeriesGCumulativePreferredStockMember 2024-12-31 0001391437 grx:SeriesGCumulativePreferredStockMember 2023-12-31 0001391437 grx:SeriesGCumulativePreferredStockMember 2022-12-31 0001391437 grx:SeriesGCumulativePreferredStockMember 2021-12-31 0001391437 grx:SeriesGCumulativePreferredStockMember 2026-01-01 2026-06-30 0001391437 grx:SeriesGCumulativePreferredStockMember 2025-01-01 2025-12-31 0001391437 grx:SeriesGCumulativePreferredStockMember 2024-01-01 2024-12-31 0001391437 grx:SeriesGCumulativePreferredStockMember 2023-01-01 2023-12-31 0001391437 grx:SeriesGCumulativePreferredStockMember 2022-01-01 2022-12-31 0001391437 grx:SeriesGCumulativePreferredStockMember 2021-01-01 2021-12-31 0001391437 grx:CumulativePreferredStocksMember 2026-01-01 2026-06-30 0001391437 grx:SeriesEPreferredStocksMember 2026-01-01 2026-06-30 iso4217:USD shares iso4217:USD shares false N-CSRS 0001391437

Gabelli Healthcare & WellnessRx Trust 2026-06-30 Investment Objective and Strategy (Unaudited) The Fund’s investment objective is long term growth of capital. Under normal market conditions, the Fund will invest at least 80% of its net assets (plus borrowings made for investment purposes) in equity securities (such as common stock and preferred stock) and income producing securities (such as fixed income debt securities and securities convertible into common stock) of domestic and foreign companies in the healthcare and wellness industries. Companies in the healthcare and wellness industries are defined as those companies which are primarily engaged in providing products, services and/or equipment related to healthcare, medical, or lifestyle needs (i.e., nutrition, weight management, and food and beverage companies primarily engaged in healthcare and wellness). “Primarily engaged,” as defined in this registration statement, means a company that derives at least 50% of its revenues or earnings from, or devotes at least 50% of its assets to, the indicated business. The above 80% policy includes investments in derivatives that have similar economic characteristics to the securities included in the 80% policy. The Fund values derivatives at market value for purposes of the 80% policy. Specific sector investments for the Fund will include, but are not limited to, dental, orthopedics, cardiology, hearing aid, life science, in-vitro diagnostics, medical supplies and products, aesthetics and plastic surgery, veterinary, pharmacy benefits management, healthcare distribution, healthcare imaging, pharmaceuticals, biotechnology, healthcare plans, healthcare services, and healthcare equipment, as well as food, beverages, nutrition and weight management. The Fund will focus on companies that are growing globally due to favorable demographic trends and may invest without limitation in securities of foreign issuers, including issuers in emerging markets. 14544733

10.53

40000000 2000000

20.00

20.00 85.99 39300000 39850000 30365000 40000000 40000000 40000000 3930000 3985000 3037000 4000000 4000000 4000000

10.00

10.00 10.00 10.00 10.00 10.00 10.00 31.92 32.41 41.62 44.66 61.16 42.99 30540000 30870000 23670000 13320000 3054000 3087000 2367000 1332000

10.00

10.00 10.00 10.00 10.00 31.92 32.41 41.62 44.66 7. Capital. The Fund is authorized to issue an unlimited number of shares of beneficial interest (par value $0.001). The Board has authorized the repurchase of its shares on the open market when the shares are trading on the NYSE at a discount of 7.5% or more (or such other percentage as the Board may determine from time to time) from the NAV of the shares. During the six months ended June 30, 2026 and the year ended December 31, 2025, the Fund repurchased and retired 505,950 and 473,143 common shares in the open market at investments of $4,801,933 and $4,501,585, respectively, at average discounts of approximately 9.78% and 10.13% from its NAV. Transactions in shares of beneficial interest were as follows: <table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Six Months Ended June 30, 2026 (Unaudited)</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="padding-bottom: 1pt; font-size: 10pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">Year Ended December 31, 2025</td> <td style="padding-bottom: 1pt; font-size: 10pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Net decrease from repurchase of common shares</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right">(505,950</td> <td style="width: 1%; text-align: left">)</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">(4,801,933</td> <td style="width: 1%; text-align: left">)</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right">(473,143</td> <td style="width: 1%; text-align: left">)</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">(4,501,585</td> <td style="width: 1%; text-align: left">)</td></tr> </table> <p id="xdx_840_ecef--PreferredStockRestrictionsOtherTextBlock_hcef--RiskAxis__custom--CumulativePreferredStocksMember_dU_zFBonZ56Y3b6" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"> The Fund’s Declaration of Trust, as amended, authorizes the issuance of an unlimited number of shares of $0.001 par value Preferred Shares. The Preferred Shares are senior to the common shares and result in the financial leveraging of the common shares. Such leveraging tends to magnify both the risks and opportunities to common shareholders. Dividends on Preferred Shares are cumulative. The Fund is required by the 1940 Act and by the Statement of Preferences to meet certain asset coverage tests with respect to the Preferred Shares. If the Fund fails to meet these requirements and does not correct such failure, the Fund may be required to redeem, in part or in full, the Preferred Shares at their liquidation preference plus an amount equal to the accumulated and unpaid dividends whether or not declared on such shares in order to meet these requirements. Additionally, failure to meet the foregoing asset coverage requirements could restrict the Fund’s ability to pay dividends to common shareholders and could lead to sales of portfolio securities at inopportune times. The income received on the Fund’s assets may vary in a manner unrelated to the fixed rates, which could have either a beneficial or detrimental impact on net investment income and gains available to common shareholders. As of June 30, 2026 the Fund had an effective shelf registration authorizing the issuance of $200 million in common or preferred shares. On December 18, 2020, the Fund issued 2,000,000 shares of Series C 4.00% Cumulative Preferred Shares receiving $39,841,048 after the deduction of offering expenses of $158,952. The Series C Preferred had a liquidation value of $20 per share, an annual dividend rate of 4.00%, and was redeemed by the Fund on December 18, 2024. On December 26, 2022, 2,000,000 shares of the Series C were put back to the Fund at their liquidation preference of $20 per share plus accrued and unpaid dividends. On October 15, 2021, the Fund issued 4,000,000 shares of Series E 5.20% Cumulative Preferred Shares receiving $39,875,000 after the deduction of actual offering expenses of $100,000. On January 6, 2024, February 29, 2024, June 26, 2024, October 6, 2025, October 28, 2025, and December 26, 2025, the Fund issued 100,000 shares, 810,000 shares, 200,000 shares, 100,014 shares, 200,000 shares, and 2,586,000 shares of Series E Preferred, respectively, receiving $990,000, $8,080,000, $2,000,000, $1,000,140, $2,000,000, and $25,860,000, respectively. The Series E Preferred has a liquidation value of $10 per share and had an annual dividend rate of 4.00%. Effective February 12, 2024, the dividend rate on Series E Preferred shares increased to 5.20%. The Series E Preferred Shares are callable at the Fund’s option at any time commencing on December 26, 2024. The Series E Preferred Shares were puttable on June 26, 2024. The Board approved June 26, 2026, December 26, 2026, June 26, 2027, December 26, 2027, and June 26, 2028 as additional put dates for the Series E Preferred. The Series E Preferred was subject to a mandatory shareholder put out of which shareholders could opt on December 26, 2025 and 1,399,014 shares opted out of the mandatory put subject to mandatory redemption by the Fund on December 26, 2028. On June 26, 2024, June 26, 2025, December 26, 2025, and June 26, 2026, 963,500 shares, 1,420,000 shares, 517,500 shares, and 55,000 shares of Series E Preferred, respectively, were put back to the Fund at their liquidation preference of $10 per share. At June 30, 2026, 3,930,014 shares of Series E Preferred were outstanding and accrued dividends amounted to $22,866. On January 18, 2023 and February 1, 2023, the Fund issued 2,100,000 shares and 295,500 shares, respectively, of Series G 5.20% Cumulative Preferred Shares, receiving $23,755,000 after the deduction of actual offering expenses of $200,000. On January 8, 2024, February 9, 2024, and June 26, 2024, the Fund issued 100,000 shares; 810,000 shares; and 200,000 shares of Series G, respectively, receiving $1,000,000; $8,100,000; and $2,000,000, respectively. On October 30, 2025 and December 26, 2025, the Fund issued 1,800,000 shares and 100,000 shares, respectively, of Series G 5.20% Cumulative Preferred Shares, receiving $18,000,000 and $1,000,000, respectively. The Series G Preferred has a liquidation value of $10 per share and an annual dividend rate of 5.20%. The Series G Preferred Shares were puttable on June 26, 2024 and December 26, 2024, and the Board approved December 26, 2025, June 26, 2026, December 26, 2026, June 26, 2027, and December 26, 2027 as additional put dates. On December 26, 2023, 1,098,500 shares were put back to the Fund at their liquidation preference plus accumulated and unpaid dividends, leaving 1,297,000 shares. The Fund issued 35,000 shares on December 26, 2023, receiving $345,000 after the deduction of estimated offering expenses. The Series G Preferred was subject to a mandatory shareholder put out of which shareholders could opt on June 26, 2025, and 1,712,000 shares opted out of the put subject to mandatory redemption by the Fund on June 26, 2028. On June 26, 2024, December 26, 2024, June 26, 2025, December 26, 2025, and June 26, 2026, 10,000, 65,000, 655,000, 525,000, and 33,000 Series G Preferred, respectively, were put back to the Fund at their liquidation preference of $10 per share. At June 30, 2026, 3,054,000 shares of Series G Preferred were outstanding and accrued dividends amounted to $1,891. <p id="xdx_841_ecef--OutstandingSecuritiesTableTextBlock_hcef--RiskAxis__custom--CumulativePreferredStocksMember_zw2U4ubQ5La3" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: left">Series</td> <td> </td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">Issue Date</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Authorized</td> <td> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of Shares Outstanding at 6/30/2026</td> <td style="font-weight: bold"> </td> <td> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Net Proceeds</td> <td> </td> <td> </td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">2026 Dividend Rate Range</td> <td> </td> <td style="border-bottom: Black 1pt solid; text-align: center">Dividend Rate at 6/30/2026</td> <td> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Accrued Dividends at 6/30/2026</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98E_ecef--OutstandingSecurityTitleTextBlock_c20260101__20260630__cef--RiskAxis__custom--SeriesEPreferredStocksMember_zX5laXrkta8l" style="vertical-align: top; width: 12%; text-align: left; text-indent: -0.125in; padding-left: 0.125in">E 5.200%</td> <td style="width: 2%"> </td> <td style="vertical-align: top; width: 15%; text-align: center">October 15, 2021</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_986_ecef--OutstandingSecurityAuthorizedShares_c20260101__20260630__cef--RiskAxis__custom--SeriesEPreferredStocksMember_zkAPKtBV4zXe" style="width: 9%; text-align: right">4,000,000</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_987_ecef--OutstandingSecurityNotHeldShares_c20260101__20260630__cef--RiskAxis__custom--SeriesEPreferredStocksMember_za2Ns6Db8qQ3" style="width: 9%; text-align: right">3,930,014</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">39,875,000</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="vertical-align: top; width: 9%; text-align: center">Fixed Rate</td> <td style="width: 2%"> </td> <td style="width: 9%; text-align: center">5.200%</td> <td style="width: 2%; text-align: left"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">22,866</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_988_ecef--OutstandingSecurityTitleTextBlock_c20260101__20260630__cef--RiskAxis__custom--SeriesGCumulativePreferredStockMember_z8A2Eqr8SWM6" style="vertical-align: top; text-align: left; text-indent: -0.125in; padding-left: 0.125in">G 5.200%</td> <td> </td> <td style="vertical-align: top; text-align: center">Various</td> <td> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_980_ecef--OutstandingSecurityAuthorizedShares_c20260101__20260630__cef--RiskAxis__custom--SeriesGCumulativePreferredStockMember_zFl2hleT1wWe" style="text-align: right">2,395,500</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_989_ecef--OutstandingSecurityNotHeldShares_c20260101__20260630__cef--RiskAxis__custom--SeriesGCumulativePreferredStockMember_z2R9sNgbwUBe" style="text-align: right">3,054,000</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">23,755,000</td> <td style="text-align: left"> </td> <td> </td> <td style="vertical-align: top; text-align: center">Fixed Rate</td> <td> </td> <td style="text-align: center">5.200%</td> <td style="text-align: left"> </td> <td style="text-align: left">$</td> <td style="text-align: right">1,891</td> <td style="text-align: left"> </td></tr> </table> <p id="xdx_84B_ecef--SecurityVotingRightsTextBlock_hcef--RiskAxis__custom--CumulativePreferredStocksMember_dU_zVK4ffN3TQn" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">The holders of Preferred Shares generally are entitled to one vote per share held on each matter submitted to a vote of shareholders of the Fund and will vote together with holders of common stock as a single class. The holders of Preferred Shares voting together as a single class also have the right currently to elect two Trustees and under certain circumstances are entitled to elect a majority of the Board. In addition, the affirmative vote of a majority of the votes entitled to be cast by holders of all outstanding shares of the Preferred Shares, voting as a single class, will be required to approve any plan of reorganization adversely affecting the Preferred Shares, and the approval of two-thirds of each class, voting separately, of the Fund’s outstanding voting stock must approve the conversion of the Fund from a closed-end to an open-end investment company. The approval of a majority (as defined in the 1940 Act) of the outstanding Preferred Shares and a majority (as defined in the 1940 Act) of the Fund’s outstanding voting securities are required to approve certain other actions, including changes in the Fund’s investment objectives or fundamental investment policies. <p id="xdx_840_ecef--PreferredStockRestrictionsOtherTextBlock_hcef--RiskAxis__custom--CumulativePreferredStocksMember_dU_zFBonZ56Y3b6" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"> The Fund’s Declaration of Trust, as amended, authorizes the issuance of an unlimited number of shares of $0.001 par value Preferred Shares. The Preferred Shares are senior to the common shares and result in the financial leveraging of the common shares. Such leveraging tends to magnify both the risks and opportunities to common shareholders. Dividends on Preferred Shares are cumulative. The Fund is required by the 1940 Act and by the Statement of Preferences to meet certain asset coverage tests with respect to the Preferred Shares. If the Fund fails to meet these requirements and does not correct such failure, the Fund may be required to redeem, in part or in full, the Preferred Shares at their liquidation preference plus an amount equal to the accumulated and unpaid dividends whether or not declared on such shares in order to meet these requirements. Additionally, failure to meet the foregoing asset coverage requirements could restrict the Fund’s ability to pay dividends to common shareholders and could lead to sales of portfolio securities at inopportune times. The income received on the Fund’s assets may vary in a manner unrelated to the fixed rates, which could have either a beneficial or detrimental impact on net investment income and gains available to common shareholders. As of June 30, 2026 the Fund had an effective shelf registration authorizing the issuance of $200 million in common or preferred shares. On December 18, 2020, the Fund issued 2,000,000 shares of Series C 4.00% Cumulative Preferred Shares receiving $39,841,048 after the deduction of offering expenses of $158,952. The Series C Preferred had a liquidation value of $20 per share, an annual dividend rate of 4.00%, and was redeemed by the Fund on December 18, 2024. On December 26, 2022, 2,000,000 shares of the Series C were put back to the Fund at their liquidation preference of $20 per share plus accrued and unpaid dividends. On October 15, 2021, the Fund issued 4,000,000 shares of Series E 5.20% Cumulative Preferred Shares receiving $39,875,000 after the deduction of actual offering expenses of $100,000. On January 6, 2024, February 29, 2024, June 26, 2024, October 6, 2025, October 28, 2025, and December 26, 2025, the Fund issued 100,000 shares, 810,000 shares, 200,000 shares, 100,014 shares, 200,000 shares, and 2,586,000 shares of Series E Preferred, respectively, receiving $990,000, $8,080,000, $2,000,000, $1,000,140, $2,000,000, and $25,860,000, respectively. The Series E Preferred has a liquidation value of $10 per share and had an annual dividend rate of 4.00%. Effective February 12, 2024, the dividend rate on Series E Preferred shares increased to 5.20%. The Series E Preferred Shares are callable at the Fund’s option at any time commencing on December 26, 2024. The Series E Preferred Shares were puttable on June 26, 2024. The Board approved June 26, 2026, December 26, 2026, June 26, 2027, December 26, 2027, and June 26, 2028 as additional put dates for the Series E Preferred. The Series E Preferred was subject to a mandatory shareholder put out of which shareholders could opt on December 26, 2025 and 1,399,014 shares opted out of the mandatory put subject to mandatory redemption by the Fund on December 26, 2028. On June 26, 2024, June 26, 2025, December 26, 2025, and June 26, 2026, 963,500 shares, 1,420,000 shares, 517,500 shares, and 55,000 shares of Series E Preferred, respectively, were put back to the Fund at their liquidation preference of $10 per share. At June 30, 2026, 3,930,014 shares of Series E Preferred were outstanding and accrued dividends amounted to $22,866. On January 18, 2023 and February 1, 2023, the Fund issued 2,100,000 shares and 295,500 shares, respectively, of Series G 5.20% Cumulative Preferred Shares, receiving $23,755,000 after the deduction of actual offering expenses of $200,000. On January 8, 2024, February 9, 2024, and June 26, 2024, the Fund issued 100,000 shares; 810,000 shares; and 200,000 shares of Series G, respectively, receiving $1,000,000; $8,100,000; and $2,000,000, respectively. On October 30, 2025 and December 26, 2025, the Fund issued 1,800,000 shares and 100,000 shares, respectively, of Series G 5.20% Cumulative Preferred Shares, receiving $18,000,000 and $1,000,000, respectively. The Series G Preferred has a liquidation value of $10 per share and an annual dividend rate of 5.20%. The Series G Preferred Shares were puttable on June 26, 2024 and December 26, 2024, and the Board approved December 26, 2025, June 26, 2026, December 26, 2026, June 26, 2027, and December 26, 2027 as additional put dates. On December 26, 2023, 1,098,500 shares were put back to the Fund at their liquidation preference plus accumulated and unpaid dividends, leaving 1,297,000 shares. The Fund issued 35,000 shares on December 26, 2023, receiving $345,000 after the deduction of estimated offering expenses. The Series G Preferred was subject to a mandatory shareholder put out of which shareholders could opt on June 26, 2025, and 1,712,000 shares opted out of the put subject to mandatory redemption by the Fund on June 26, 2028. On June 26, 2024, December 26, 2024, June 26, 2025, December 26, 2025, and June 26, 2026, 10,000, 65,000, 655,000, 525,000, and 33,000 Series G Preferred, respectively, were put back to the Fund at their liquidation preference of $10 per share. At June 30, 2026, 3,054,000 shares of Series G Preferred were outstanding and accrued dividends amounted to $1,891. <p id="xdx_841_ecef--OutstandingSecuritiesTableTextBlock_hcef--RiskAxis__custom--CumulativePreferredStocksMember_zw2U4ubQ5La3" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: left">Series</td> <td> </td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">Issue Date</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Authorized</td> <td> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of Shares Outstanding at 6/30/2026</td> <td style="font-weight: bold"> </td> <td> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Net Proceeds</td> <td> </td> <td> </td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">2026 Dividend Rate Range</td> <td> </td> <td style="border-bottom: Black 1pt solid; text-align: center">Dividend Rate at 6/30/2026</td> <td> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Accrued Dividends at 6/30/2026</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98E_ecef--OutstandingSecurityTitleTextBlock_c20260101__20260630__cef--RiskAxis__custom--SeriesEPreferredStocksMember_zX5laXrkta8l" style="vertical-align: top; width: 12%; text-align: left; text-indent: -0.125in; padding-left: 0.125in">E 5.200%</td> <td style="width: 2%"> </td> <td style="vertical-align: top; width: 15%; text-align: center">October 15, 2021</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_986_ecef--OutstandingSecurityAuthorizedShares_c20260101__20260630__cef--RiskAxis__custom--SeriesEPreferredStocksMember_zkAPKtBV4zXe" style="width: 9%; text-align: right">4,000,000</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_987_ecef--OutstandingSecurityNotHeldShares_c20260101__20260630__cef--RiskAxis__custom--SeriesEPreferredStocksMember_za2Ns6Db8qQ3" style="width: 9%; text-align: right">3,930,014</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">39,875,000</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="vertical-align: top; width: 9%; text-align: center">Fixed Rate</td> <td style="width: 2%"> </td> <td style="width: 9%; text-align: center">5.200%</td> <td style="width: 2%; text-align: left"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">22,866</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_988_ecef--OutstandingSecurityTitleTextBlock_c20260101__20260630__cef--RiskAxis__custom--SeriesGCumulativePreferredStockMember_z8A2Eqr8SWM6" style="vertical-align: top; text-align: left; text-indent: -0.125in; padding-left: 0.125in">G 5.200%</td> <td> </td> <td style="vertical-align: top; text-align: center">Various</td> <td> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_980_ecef--OutstandingSecurityAuthorizedShares_c20260101__20260630__cef--RiskAxis__custom--SeriesGCumulativePreferredStockMember_zFl2hleT1wWe" style="text-align: right">2,395,500</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_989_ecef--OutstandingSecurityNotHeldShares_c20260101__20260630__cef--RiskAxis__custom--SeriesGCumulativePreferredStockMember_z2R9sNgbwUBe" style="text-align: right">3,054,000</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">23,755,000</td> <td style="text-align: left"> </td> <td> </td> <td style="vertical-align: top; text-align: center">Fixed Rate</td> <td> </td> <td style="text-align: center">5.200%</td> <td style="text-align: left"> </td> <td style="text-align: left">$</td> <td style="text-align: right">1,891</td> <td style="text-align: left"> </td></tr> </table> E 5.200% 4000000 3930014 G 5.200% 2395500 3054000 <p id="xdx_84B_ecef--SecurityVotingRightsTextBlock_hcef--RiskAxis__custom--CumulativePreferredStocksMember_dU_zVK4ffN3TQn" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">The holders of Preferred Shares generally are entitled to one vote per share held on each matter submitted to a vote of shareholders of the Fund and will vote together with holders of common stock as a single class. The holders of Preferred Shares voting together as a single class also have the right currently to elect two Trustees and under certain circumstances are entitled to elect a majority of the Board. In addition, the affirmative vote of a majority of the votes entitled to be cast by holders of all outstanding shares of the Preferred Shares, voting as a single class, will be required to approve any plan of reorganization adversely affecting the Preferred Shares, and the approval of two-thirds of each class, voting separately, of the Fund’s outstanding voting stock must approve the conversion of the Fund from a closed-end to an open-end investment company. The approval of a majority (as defined in the 1940 Act) of the outstanding Preferred Shares and a majority (as defined in the 1940 Act) of the Fund’s outstanding voting securities are required to approve certain other actions, including changes in the Fund’s investment objectives or fundamental investment policies.